|
시장보고서
상품코드
1581969
세계의 프리미엄 백내장 수술(PCS) 시장(2023년) : 상위 13개국 분석(2023-2029년)2024 Premium Cataract Surgery Market Report: Analysis of the Top 13 Countries for 2023 to 2029 |
||||||
세계의 프리미엄 백내장 수술(PCS) 시장에 대해 조사했으며, 시장 개요와 세계의 백내장 수술과 제품 매출의 분석, 중요 동향, 향후 성공을 향한 주요 요인의 분석 및 상위 13개국의 시장 동향을 제공하고 있습니다.
목차
- 노안 교정 안내 렌즈
- 토릭 안내 렌즈
- 중간 최적화 안내 렌즈
- 수술후 조절 안내 렌즈
- FLACS 레이저
- FLACS 활꼴절개법
- manual limbal relaxing incisions
- 엑시머 IOL 강화
- 상위 13 PCS 시장(미국, 중국, 일본, 프랑스, 독일, 브라질, 캐나다, 인도, 스페인, 한국, 호주, 영국, 이탈리아)의 개요와 상세한 개요
- 각국의 개요
- 국가별 백내장 수술 비용 분석
- 국가별 PCS 수술과 제조업체의 매출 예측
- 국가별 PCS 수술에 의한 의료 제공자의 매출과 예측
- 백내장 전용, 백내장/굴절 교정, 굴절 교정 전용 외과의가 각 주요 국가에서 시행한 PCS 수술의 비율
- 국가별 및 세계의 PCS 시장에서 제조업체 매출 시장 점유율
- 국가별 가장 중요한 PCS 안과 병원과 클리닉 리스트
- 다음으로 중요한 PCS 6개국의 시장 규모 순위
What's New:
The new "2024 Premium Cataract Surgery Market Report" now features a five-year history of PC-IOLs, toric IOLs, and FLACS for each of the top 13 premium cataract surgery country markets in the world. For each of these countries, the report also analyzes the recent economy and projects its impact on the elderly populations that account for most premium procedures.
INFOGRAPHICS
The report also explores the long list of recently launched new products that are destined to impact the premium cataract market-including the Carl Zeiss Micor 700 cataract handpiece, which has the potential to drive adoption of office-based cataract surgery; the Rayner Galaxy spiral trifocal IOL and many other new PC-IOLs; and the Lensar Ally, which is expected to drive growth in FLACS procedures.
The new report also examines and explains the dramatic drop in premium procedures in South Korea and outlines the potential recovery of that market over the next five years.
The "2024 Premium Cataract Surgery Market Report" is designed to provide insights into the most important premium cataract surgery (PCS) markets in the world. We've selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2024 PCS manufacturer revenue, they are: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.
For each of these countries, the report focuses on specific characteristics considered vital to the understanding of the opportunities for companies planning to market premium cataract surgery devices or looking to assess the value of each market.
Contents:
The report offers an in-depth examination of the 2024 premium cataract surgery (PCS) market. It includes analysis of the global PCS procedure and product revenue, identification of important trends, and discussion of key factors for future success. The following information is also included:
- Presbyopia-correcting, toric, intermediate-optimized, and post-op adjustable IOLs, FLACS lasers, FLACS arcuate incisions, manual limbal relaxing incisions, and excimer IOL enhancements.
- Snapshots and in-depth profiles of the top 13 PCS markets: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.
- Individual country executive summary.
- Analysis of the cost of public and private cataract surgery options by country.
- Forecasts for PCS procedures and manufacturer revenue by country.
- Forecasts for provider revenue resulting from PCS procedures by country.
- Percentage of PCS procedures performed in each key country by cataract-only, cataract/refractive, and refractive-only surgeons.
- Manufacturer revenue market shares of the PCS market in each country and globally.
- Listing of the most important PCS eye hospitals and clinics by country.
- A list of the next six most important PCS countries ranked by market size.
